Promote molecular epidemiological studies of human mycoplasmas.
Propose the standard procedures for comparison of genotyping data between studies.
Exchange information for diagnosis, detection and isolation methods.
Continue the monitoring of antimicrobial resistance.
Promote collaboration between researchers and clinicians.